Clinical Trial Update: A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON) [Phase 3]

View source ↗

Summary

This is a Phase 3 master protocol study (SHINE-ON) evaluating Mirikizumab (LY3074828) in pediatric participants with Ulcerative colitis or Crohn's disease; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• Mirikizumab (mirikizumab)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Ulcerative Colitis, Ulcerative Colitis Chronic | Phase 3 | Status: RECRUITING